Drug Discovery

How Does Fructose Fuel Cancer Growth?
Research & Development How Does Fructose Fuel Cancer Growth?

Fructose, a common sugar found in many everyday foods, has been discovered to indirectly contribute to the growth of tumors. This potentially transformative finding opens new avenues for cancer treatment. Building upon early twentieth-century research by German physiologist Otto Warburg, which

Harnessing Tumor Organoids for Advanced Cancer Research
Biotech & Bioprocessing Harnessing Tumor Organoids for Advanced Cancer Research

In the quest to understand and treat cancer, researchers have faced significant obstacles with traditional models such as two-dimensional cell cultures and in vivo xenografts. These methods, while useful in their own right, often fall short in accurately replicating the complex architecture and

Revolutionizing Surgery: DIP Technology in 3D Bioprinting
Biotech & Bioprocessing Revolutionizing Surgery: DIP Technology in 3D Bioprinting

3D printing technology is paving the way for significant advancements in the medical field, particularly within plastic and reconstructive surgery. The introduction of dynamic interface printing (DIP) promises to transform tissue engineering, making it possible to create patient-specific,

Why Are Hedge Funds Investing Big in AI and MedTech Healthcare?
Management & Regulatory Why Are Hedge Funds Investing Big in AI and MedTech Healthcare?

The fourth quarter of 2024 witnessed a significant surge in hedge fund investments focused on the healthcare sector, particularly emphasizing advancements in artificial intelligence (AI), biotechnology, and medical technology (MedTech). This pivotal period showcased growing confidence among

CROs Shift to Alternative Methods Following FDA Animal Testing Phase-Out
Research & Development CROs Shift to Alternative Methods Following FDA Animal Testing Phase-Out

Chinese contract research organization GemPharmatech has expanded its presence in the United States with a new facility in San Diego, announced on April 17. The facility is designed for laboratories and housing genetically engineered mouse models, aimed at enhancing their capabilities in offering

Can Glycomine's $115M Funded Drug Transform Rare Disease Treatment?
Tech & Innovation Can Glycomine's $115M Funded Drug Transform Rare Disease Treatment?

Glycomine, a leading biotechnology company based in San Francisco, has achieved a notable milestone by raising $115 million in funding for their pioneering project, GLM101. This development is particularly significant in an economic environment where securing substantial capital remains

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later